AJANI J A , D’AMICO T A , BENTREM D J , et al . Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology [J ] . J Natl Compr Canc Netw , 2023 , 21 ( 4 ): 393 - 422 .

OBERMANNOVÁ R L , LEONG T , ESMO Guidelines Committee . ESMO clinical practice guideline interim update on the treatment of locally advanced oesophageal and oesophagogastric junction adenocarcinoma and metastatic squamous-cell carcinoma [J ] . ESMO Open , 2025 , 10 ( 2 ): 104134 .

ZHANG S Q , GUO J D , ZHANG H Y , et al . Metastasis pattern and prognosis in men with esophageal cancer patients: A SEER-based study [J ] . Medicine (Baltimore) , 2021 , 100 ( 25 ): e26496 .

MURPHY C M , WANG K , WACHUKU C , et al . Metastatic gastric adenocarcinoma to the cutaneous neck and chest wall [J ] . SAGE Open Med Case Rep , 2024 , 12 : 2050313 X241231515.

CULLEN G . Esophageal cancer: a case study of a rare metastatic esophageal squamous cell carcinoma [J ] . Clin J Oncol Nurs , 2020 , 24 ( 4 ): 352 - 355 . DOI: 10.1188/20.CJON.352-355 http://doi.org/10.1188/20.CJON.352-355

MIYATA M , SHIOZAKI H , IIHARA K , et al . Relationship between E-cadherin expression and lymph-node metastasis in human esophageal cancer [J ] . Int J Oncol , 1994 , 4 ( 1 ): 61 - 65 .

WENG W H , YIN J Y , ZHANG Y , et al . Metastasis-associated protein 1 promotes tumor invasion by downregulation of E-cadherin [J ] . Int J Oncol , 2014 , 44 ( 3 ): 812 - 818 .

NEMOTO M , ICHIKAWA H , NAGAHASHI M , et al . Phospho-sphingosine kinase 1 expression in lymphatic spread of esophageal squamous cell carcinoma [J ] . J Surg Res , 2019 , 234 : 123 - 131 . DOI: S0022-4804(18)30637-1 http://doi.org/S0022-4804(18)30637-1

ZHENG S Y , ZHANG Y , GONG X Z , et al . CREB1 regulates RECQL4 to inhibit mitophagy and promote esophageal cancer metastasis [J ] . J Clin Biochem Nutr , 2024 , 75 ( 2 ): 102 - 110 . DOI: 10.3164/jcbn.23-118 http://doi.org/10.3164/jcbn.23-118

GERDES J . Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies [J ] . Semin Cancer Biol , 1990 , 1 ( 3 ): 199 - 206 .

BUTERA A , AMELIO I . Deciphering the significance of p53 mutant proteins [J ] . Trends Cell Biol , 2025 , 35 ( 3 ): 258 - 268 .

JANIC A , ABAD E , AMELIO I . Decoding p 53 tumor suppression: a crosstalk between genomic stability and epigenetic control? [J ] . Cell Death Differ , 2025 , 32 ( 1 ): 1 - 8 .

GSCHNELL M , VOLBERG C , HAUSER C , et al . Cutaneous metastases: from epidemiology to therapy [J ] . J Dtsch Dermatol Ges , 2024 , 22 ( 7 ): 974 - 993 .

GAO Y C , ZHANG H C , TANG L , et al . Cancer nanobombs delivering artoxplatin with a polyigniter bearing hydrophobic ferrocene units upregulate PD-L1 expression and stimulate stronger anticancer immunity [J ] . Adv Sci (Weinh) , 2024 , 11 ( 4 ): e2300806 .